HDAC11 and neoplasm: Histone deacetylase 11 (HDAC11) inhibits histone acetylation of serine/threonine kinase 11(STK11) promoter to inhibit its transcription, thereby, promoting the glycolysis pathway and leading to tumor stemness (Bi et al., 2021).